Research ArticleArticle
Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis
J. Christiaan van Denderen, Ingrid M. Visman, Michael T. Nurmohamed, Maria S.A. Suttorp-Schulten and Irene E. van der Horst-Bruinsma
The Journal of Rheumatology August 2014, jrheum.131289; DOI: https://doi.org/10.3899/jrheum.131289
J. Christiaan van Denderen
From the Department of Rheumatology, Jan van Breemen Research Institute Reade, and Department of Rheumatology, VU University Medical Center; and Department of Ophthalmology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. Supported by Abbott and by the Jan van Breemen Research Institute. J.C. van Denderen, MD; I.M. Visman, Department of Rheumatology, Jan van Breemen Research Institute Reade; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Jan van Breemen Research Institute Reade, and Department of Rheumatology, VU University Medical Center; M.S.A. Suttorp-Schulten, MD, PhD, Department of Ophthalmology, Onze Lieve Vrouwe Gasthuis; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, VU University Medical Center. Address correspondence to Dr. I.E. van der Horst-Bruinsma, VU University Medical Centre, Department of Rheumatology, PO Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail: ie.vanderhorst@vumc.nl. Accepted for publication May 15, 2014.
Ingrid M. Visman
From the Department of Rheumatology, Jan van Breemen Research Institute Reade, and Department of Rheumatology, VU University Medical Center; and Department of Ophthalmology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. Supported by Abbott and by the Jan van Breemen Research Institute. J.C. van Denderen, MD; I.M. Visman, Department of Rheumatology, Jan van Breemen Research Institute Reade; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Jan van Breemen Research Institute Reade, and Department of Rheumatology, VU University Medical Center; M.S.A. Suttorp-Schulten, MD, PhD, Department of Ophthalmology, Onze Lieve Vrouwe Gasthuis; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, VU University Medical Center. Address correspondence to Dr. I.E. van der Horst-Bruinsma, VU University Medical Centre, Department of Rheumatology, PO Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail: ie.vanderhorst@vumc.nl. Accepted for publication May 15, 2014.
Michael T. Nurmohamed
From the Department of Rheumatology, Jan van Breemen Research Institute Reade, and Department of Rheumatology, VU University Medical Center; and Department of Ophthalmology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. Supported by Abbott and by the Jan van Breemen Research Institute. J.C. van Denderen, MD; I.M. Visman, Department of Rheumatology, Jan van Breemen Research Institute Reade; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Jan van Breemen Research Institute Reade, and Department of Rheumatology, VU University Medical Center; M.S.A. Suttorp-Schulten, MD, PhD, Department of Ophthalmology, Onze Lieve Vrouwe Gasthuis; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, VU University Medical Center. Address correspondence to Dr. I.E. van der Horst-Bruinsma, VU University Medical Centre, Department of Rheumatology, PO Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail: ie.vanderhorst@vumc.nl. Accepted for publication May 15, 2014.
Maria S.A. Suttorp-Schulten
From the Department of Rheumatology, Jan van Breemen Research Institute Reade, and Department of Rheumatology, VU University Medical Center; and Department of Ophthalmology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. Supported by Abbott and by the Jan van Breemen Research Institute. J.C. van Denderen, MD; I.M. Visman, Department of Rheumatology, Jan van Breemen Research Institute Reade; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Jan van Breemen Research Institute Reade, and Department of Rheumatology, VU University Medical Center; M.S.A. Suttorp-Schulten, MD, PhD, Department of Ophthalmology, Onze Lieve Vrouwe Gasthuis; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, VU University Medical Center. Address correspondence to Dr. I.E. van der Horst-Bruinsma, VU University Medical Centre, Department of Rheumatology, PO Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail: ie.vanderhorst@vumc.nl. Accepted for publication May 15, 2014.
Irene E. van der Horst-Bruinsma
From the Department of Rheumatology, Jan van Breemen Research Institute Reade, and Department of Rheumatology, VU University Medical Center; and Department of Ophthalmology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. Supported by Abbott and by the Jan van Breemen Research Institute. J.C. van Denderen, MD; I.M. Visman, Department of Rheumatology, Jan van Breemen Research Institute Reade; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Jan van Breemen Research Institute Reade, and Department of Rheumatology, VU University Medical Center; M.S.A. Suttorp-Schulten, MD, PhD, Department of Ophthalmology, Onze Lieve Vrouwe Gasthuis; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, VU University Medical Center. Address correspondence to Dr. I.E. van der Horst-Bruinsma, VU University Medical Centre, Department of Rheumatology, PO Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail: ie.vanderhorst@vumc.nl. Accepted for publication May 15, 2014.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis
J. Christiaan van Denderen, Ingrid M. Visman, Michael T. Nurmohamed, Maria S.A. Suttorp-Schulten, Irene E. van der Horst-Bruinsma
The Journal of Rheumatology Aug 2014, jrheum.131289; DOI: 10.3899/jrheum.131289
Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis
J. Christiaan van Denderen, Ingrid M. Visman, Michael T. Nurmohamed, Maria S.A. Suttorp-Schulten, Irene E. van der Horst-Bruinsma
The Journal of Rheumatology Aug 2014, jrheum.131289; DOI: 10.3899/jrheum.131289